| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443688 | European Journal of Cancer | 2014 | 12 Pages |
Abstract
The benefits of aflibercept in combination with FOLFIRI in patients with mCRC previously treated with oxaliplatin were maintained across the specified patient subgroups, including in patients with or without prior bevacizumab treatment.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Josep Tabernero, Eric Van Cutsem, Radek Lakomý, Jana Prausová, Paul Ruff, Guy A. van Hazel, Vladimir M. Moiseyenko, David R. Ferry, Joseph J. McKendrick, Karen Soussan-Lazard, Soazig Chevalier, Carmen J. Allegra,